Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for

breast cancer drug delivery exosome small extracellular vesicles systematic review

Journal

Molecular therapy. Oncology
ISSN: 2950-3299
Titre abrégé: Mol Ther Oncol
Pays: United States
ID NLM: 9918752083706676

Informations de publication

Date de publication:
20 Jun 2024
Historique:
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

Breast cancer remains a significant global health concern, emphasizing the critical need for effective treatment strategies, especially targeted therapies. This systematic review summarizes the findings from

Identifiants

DOI: 10.1016/j.omton.2024.200800 PMID: 38706989 PMC: PMC11067457
pubmed: 38706989
doi: 10.1016/j.omton.2024.200800
pii: S2950-3299(24)00042-0
pmc: PMC11067457
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

200800

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Abdulwahab Teflischi Gharavi (AT)

Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.

Saeed Irian (S)

Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Azadeh Niknejad (A)

Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Keykavous Parang (K)

Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.

Mona Salimi (M)

Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.

Classifications MeSH